Dihydroisoquinolinone

ID: ALA5283140

Chembl Id: CHEMBL5283140

Max Phase: Preclinical

Molecular Formula: C9H10ClN

Molecular Weight: 131.18

Associated Items:

Names and Identifiers

Canonical SMILES:  C1=Cc2ccccc2CN1.Cl

Standard InChI:  InChI=1S/C9H9N.ClH/c1-2-4-9-7-10-6-5-8(9)3-1;/h1-6,10H,7H2;1H

Standard InChI Key:  YZHKLNCWNQOYHN-UHFFFAOYSA-N

Associated Targets(Human)

PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 131.18Molecular Weight (Monoisotopic): 131.0735AlogP: 1.76#Rotatable Bonds:
Polar Surface Area: 12.03Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.53CX LogP: 1.67CX LogD: 1.30
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.57Np Likeness Score: 0.88

References

1. Zhao Y, Zhang LX, Jiang T, Long J, Ma ZY, Lu AP, Cheng Y, Cao DS..  (2020)  The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction.,  203  [PMID:32717529] [10.1016/j.ejmech.2020.112570]

Source